Biocon Q4 Results: The pharma major’s revenue from operations in the fourth quarter of FY24 stood at ₹3,917 crore, registering a rise of four per cent, compared to ₹3,774 crore in the year-ago period.
Biocon Q4 Results: Net profit drops 57% to ₹135 crore, revenue up 4%; dividend declared
